The use of neoadjuvant chemotherapy (NACT) in oral cancer is debatable. It has two main concerns, including long-term survival improvement and organ preservation. In some studies, NACT has shown a potential role in organ preservation in oral cancer. However, indications of NACT in oral cancers are not clearly defined. Therefore, further clinical investigation is warranted to demonstrate the effectiveness and safety of NACT in oral cancer. To know more about the NACT in oral cancer, join our exclusive session with the experts, Dr.
Chirag Desai and Dr. Devendra Chaukar , on 10 th August 2026 , 4:00 PM IST onwards. Stay Tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization…